- Patent Title: Method for the diagnosis or prognosis, in vitro, of prostate cancer
-
Application No.: US14367635Application Date: 2012-12-18
-
Publication No.: US11459605B2Publication Date: 2022-10-04
- Inventor: François Mallet , Nathalie Mugnier , Philippe Perot
- Applicant: BIOMERIEUX , HOSPICES CIVILS DE LYON
- Applicant Address: FR Marcy-l'Etoile; FR Lyons
- Assignee: BIOMERIEUX,HOSPICES CIVILS DE LYON
- Current Assignee: BIOMERIEUX,HOSPICES CIVILS DE LYON
- Current Assignee Address: FR Marcy-l'Etoile; FR Lyons
- Agency: Oliff PLC
- Priority: FR1162027 20111220
- International Application: PCT/FR2012/052970 WO 20121218
- International Announcement: WO2013/093324 WO 20130627
- Main IPC: C12Q1/6869
- IPC: C12Q1/6869 ; C12Q1/6886 ; G01N33/574
Abstract:
The present invention relates to a method for the in vitro diagnosis or prognosis of prostate cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, once isolated, as one or more molecular marker(s) and a kit comprising at least one specific binding partner of at least one of the expression products of the HERV nucleic acid sequences.
Public/Granted literature
- US20140370503A1 METHOD FOR THE DIAGNOSIS OR PROGNOSIS, IN VITRO, OF PROSTATE CANCER Public/Granted day:2014-12-18
Information query
